The interaction of HMGB1 with toll-like receptor 4 (TLR4) induces muscle weakness and fatigue in patients with myositis [27], while the binding of HMGB1 to the receptor for advanced glycation end-products (RAGE) decreases survival in muscle-wasting mouse models [28]. This evidence concerns the gene TLR4 and myositis disease.